South Korea approves human trials of Celltrion’s COVID-19 antibody drug

South Korea on Friday approved an early stage clinical trial of Celltrion Inc’s experimental COVID-19 treatment drug, making it the country’s first such antibody drug to be tested on humans. Drugmaker …

( read original story …)